This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sysmex Corporation. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Hiroyoshi Nishio: Innovator in Centralized Monitoring Systems
Introduction
Hiroyoshi Nishio is a prominent inventor based in Himeji, Japan. He is known for his contributions to the field of medical technology, particularly in the development of centralized monitoring systems. His innovative work has led to advancements that enhance the efficiency and accuracy of hematology analysis.
Latest Patents
Hiroyoshi Nishio holds a patent for a "Centralized monitoring system, analyzing system and centralized monitoring method." This invention includes a sophisticated analyzing system that features multiple inspection lines, each equipped with a reagent supplying apparatus and hematology analyzers. These analyzers process measurement samples derived from blood samples and reagents supplied by the apparatus. The system is designed to optimize the monitoring and analysis of hematological data through a computer interface that integrates and displays the information.
Career Highlights
Hiroyoshi Nishio is currently employed at Sysmex Corporation, a leading company in the field of medical diagnostics. His work at Sysmex has allowed him to focus on innovative solutions that improve laboratory efficiency and patient care. His dedication to research and development has positioned him as a key figure in the advancement of hematology technology.
Collaborations
Hiroyoshi Nishio has collaborated with notable colleagues, including Hiroyuki Tanaka. These partnerships have fostered an environment of innovation and have contributed to the successful development of new technologies in the medical field.
Conclusion
Hiroyoshi Nishio's contributions to centralized monitoring systems exemplify the impact of innovation in medical technology. His work continues to influence the way hematological analysis is conducted, ultimately benefiting healthcare providers and patients alike.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
